跳至主要内容
临床试验/EUCTR2015-004150-17-SE
EUCTR2015-004150-17-SE进行中(未招募)不适用

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

Västra Götalandsregionen0 个研究点开始时间: 2015年10月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Surgical procedure: Oesophagectomy, total gastrectomy or pancreatic duodenectomy (Whipple procedure) or matched
  • unoperated healthy controls
  • 2. At least one year in remission post-resection (surgical groups)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • 1. Pregnancy, breastfeeding
  • 2. Significant and persistent chemoradiotherapy and/or surgical complication
  • 3. Other previous upper gastrointestinal surgery
  • 4. Unwell or unable to eat
  • 5. Other disease or medications which may affect satiety gut hormone responses
  • 6. Active and significant psychiatric illness including substance misuse
  • 7. Cognitive or communication issues or any factors affecting capacity to consent to participation
  • 8. History of significant food allergy, certain dietary restrictions
  • 9. Confirmed or suspected residual or recurrent disease after surgery, second primary malignancy
  • 10. Requiring adjuvant chemotherapy
  • 11. Contraindication to octreotide administration
  • 12. History of eating disorder

研究者

相似试验